Aspira Women's Health® Reports Second Quarter 2023 Financial Results

Continued growth trend with second quarter revenue of $2.5 million, an increase of 23% over the second quarter of 2022.OvaSuiteSM volume of 6,289 ...

Related Keywords

Texas ,United States ,Connecticut ,New York ,American ,Monique Kosse ,Winfred Parnell ,Nicole Sandford ,Torsten Hombeck ,Gerard Reilly ,Connecticut Department Of Economic ,Drug Administration ,Aspira Women Health Inc ,Lifesci Advisors ,Clinical Research ,Aspira Women Health ,Axia Women Health ,Nasdaq ,Community Development ,American Society Of Clinical Oncology ,Aspira Women Health Investor Relations ,Chief Executive ,Recent Corporate ,Connecticut Department ,Clinical Oncology ,Aspira Women ,Axia Women ,Chief Financial ,Aspira Board ,Bryan Phan ,Chief Scientific ,Chief Operating Officer ,Health Investor Relations ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Medicare Administrative Carrier ,Aspira Labs ,Relations Contact ,Sci Advisors ,Except Share ,Par Value Amounts ,Stockholder Equity ,Consolidated Statements ,Per Share Amounts ,